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ABSTRACT: Members of the LanL family of lanthionine synthetases consist of three catalytic domains, an
N-terminal pSer/pThr lyase domain, a central Ser/Thr kinase domain, and a C-terminal lanthionine cyclase
domain. The N-terminal lyase domain has sequence homology with members of the OspF family of effector
proteins. In this study, the residues in the lyase domain of VenL that are conserved in the active site of OspF
proteinsweremutatedto evaluate their importance for catalysis.In addition,residues that arefully conserved
in the LanL family but not in the OspF family were mutated. Activity assays with these mutant proteins are
consistent with a model in which Lys80 in VenL deprotonates the R-proton of pSer/pThr residues to initiate
theeliminationreaction.Lys51isproposedtoactivatethisprotonbycoordinationtothecarbonylofthepSer/
pThr, and His53 is believed to protonate the phosphate leaving group. These functions are very similar to the
correspondinghomologousresiduesinOspFproteins.Ontheotherhand,recognitionofthephosphategroup
of pSer/pThr appears to be achieved differently in VenL than in the OspF proteins. Arg156 and Lys103 are
thought to interact with the phosphate group on the basis of a structural homology model.
Lantipeptides are posttranslationally modified peptide natural
products that contain thioether cross-links named lanthionine
(Lan)
1andmethyllanthionine(MeLan)(1,2).Lantipeptideswith
antimicrobial activities are called lantibiotics (3). The character-
istic thioethers are incorporated by the site-specific dehydration
of Ser and Thr residues in the precursor peptide to dehydroala-
nine (Dha) and dehydrobutyrine (Dhb), respectively, and sub-
sequent stereoselective intramolecular Michael-type addition of
cysteine thiols to the dehydro amino acids. The resulting poly-
cyclic peptides provide protease resistance (4) and restrict con-
formational freedom such that molecular targets can be re-
cognized with higher affinities. Not surprisingly given the highly
efficient route to such structures, at least four different biosyn-
theticroutestolantipeptideshavebeenuncoveredtodate(Figure
1A) (1, 3, 5, 6). On the basis of the type of lanthionine synthetase
that forms the lanthionine rings, lantibiotics/lantipeptides have
been categorized into four classes. In class I, dedicated dehydra-
tase (LanB) and cyclase (LanC) enzymes are responsible for the
dehydration and cyclization (the term Lan is used as a generic
descriptor of proteins involved in lantipeptide biosynthesis). In
contrast, multifunctional enzymes (LanM, RamC/LabKC, or
LanL) catalyze both dehydration andcyclization reactions in the
other three classes of lantibiotics/lantipeptides (1, 7, 8). LanM
and LanL enzymes have LanC-like domains in their C-terminal
regions (Figure 1B), illustrating that class I, II, and IV lantipep-
tides are generated using similar cyclization strategies, in which a
zinc ion is used to activate the cysteines in the substrate for
nucleophilic attack (9-11). In contrast, the RamC and LabKC
proteins of class III lantipeptides lack the zinc ligands but also
generate (methyl)lanthionines with Dha and Dhb structures as
intermediates (8). Whereas the cyclization reaction catalyzed by
LanC and LanC-like domains is reasonably well understood
(11, 12), the molecular details of dehydration are not known for
any of the four classes of lantipeptides. LanM and LanB do not
exhibit homology with other known proteins, hampering predic-
tion of their mode of action. In vitro studies on a LanM protein
showed that the Ser and Thr residues in the substrate are first
phosphorylated to phosphoSer (pSer) and phosphoThr (pThr),
respectively, followed by β-elimination to form the dehydro
amino acids (13, 14), but the detailed molecular mechanism by
which these two enzymatic reactions are catalyzed has not been
reported.
The recent discovery of the LanL family of enzymes shed the
first light on the catalytic mechanism of formation of dehydro
amino acids during lantibiotic/lantipeptide biosynthesis. LanL
enzymes consist of an N-terminal putative pSer/Thr lyase
domain, a central Ser/Thr kinase-like domain, and a C-terminal
LanC-like cyclase domain (Figure 1B). This characteristic do-
maincompositionandinvitroenzymeassaysofdeletionmutants
ofVenL,aLanLenzymeinvolvedinbiosynthesisofvenezuelinin
Steptomyces venezuelae, suggested a unique dehydrationstrategy
in which two independent domains install Dha/Dhb via phos-
phorylation of Ser/Thr by a kinase domain and subsequent
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elimination of the phosphate from pSer/pThr by a putative
pSer/pThr lyase domain (1). The lyase domains of the LanL
family are also present in the RamC/LabKC proteins (RamC
family) of class III lantipeptides. These domains exhibit homol-
ogy to members of the OspF protein family, effector proteins
present in several pathogenic bacteria that inactivate mitogen-
activated protein kinases (MAPKs) in the host cells (15, 16).
Because OspF enzymes have pThr lyase activity, catalyzing
the irreversible β-elimination of a phosphate group from a
pThrintheMAPKstoaffordaDhbresidue,wehypothesized
that LanL and RamC families adopt similar dehydration
strategies (1).
A sequence alignment of the N-terminal putative pSer/pThr
lyase domains of LanL and RamC enzymes with OspF family
members is shown in Figure 2. This analysis reveals nine fully
conserved residues that include four of the active site residues in
the OspF family on the basis of the crystal structure of one
member, SpvC (16, 17) (Figure 2, red stars). Other conserved
residuesintheOspFfamilyarenotobservedinthelyasedomains
of class III/IV lantipeptide synthetases and vice versa. To date,
direct experimental evidence that supports the hypothesis that
LanL and RamC enzymes execute the lyase reaction by a
mechanism similar to that of the OspF family is not available.
Here, we describe mutagenesis studies aimed at determining the
essential residues for lyase activity in VenL.
MATERIALS AND METHODS
General Materials. All oligonucleotides were purchased
from Operon Technologies, Integrated DNA Technologies, or
Sigma-Aldrich. Restriction endonucleases, DNA polymerases,
and T4 DNA ligase were purchased from Invitrogen or New
England Biolabs. Media for bacterial culture and chemicals were
purchased from Difco laboratories, CalBiochem, Aldrich, or
Fisher Scientific unless noted otherwise and used without further
purification. Escherichia coli DH5R was used as host for cloning
and plasmid propagation, and E. coli BL21(DE3) was used as a
host for protein expression. Cloning vectors (pET15 and pET28)
were obtained from Novagen. pET28b vectors containing the
venL-ΔC or lctM genes have been described in the literature
(1, 18). VenA, LctA, VenL, and LctM were expressed in E. coli
and purified as previously reported (1, 18).
General Methods. All polymerase chain reaction (PCR)
amplifications were conducted with an automated thermocycler
(PTC-100 or PTC-150, MJ Research). DNA sequencing was
conducted using the appropriate primers by the Biotechnology
Center of the University of Illinois. MALDI-ToF MS was con-
ducted ona Voyager-DE-STRinstrument (Applied Biosystems).
Construction of venL-ΔC Mutant Genes. Site-directed
mutagenesisofvenL-ΔCwasperformedbymultistepPCR.First,
the amplification of venL-ΔC was conducted via 30 cycles of
denaturing (94 C for 20 s), annealing (58 C for 30 s), and
extending (72 Cf o r1 2 0s )u s i n gt h eV e n L - NdeI-FP primer and
an appropriate mutant reverse primer (see Table S1 of the
Supporting Information for oligonucleotide sequences) to yield
a5 0 fragment of the mutated venL-ΔC gene (FP reaction). The
PCR mixtures included 1  FailSafe PreMix G (PICENTRE
Biotechnologies), DMSO (4%), Platinum Pfx DNA polymerase
(0.025 unit/μL), Taq DNA polymerase (0.05 unit/μL), and
primers (1 μM each). In parallel, a PCR using an appropriate
mutant forward primer and the VenL-ΔC-HindIII-RP primer
wasalsoconductedtoproduce30 fragmentsofthemutatedvenL-
ΔC gene using the same PCR conditions that were used for the
FP reaction (RP reaction). The overlapping products from the
FP reaction and RP reaction were combined in equal amounts
and extended by five cycles of denaturing, annealing, and
extending in a solution containing 1  FailSafe PreMix G
(PICENTRE Biotechnologies), DMSO (4%), and Platinum
Pfx DNA polymerase (0.025 unit/μL). Following the extension,
the VenL-NdeI-FP and VenL-ΔC-HindIII-RP primers were
added (final concentration of 2 μM), and the reaction mixture
was incubated for 25 additional cycles of denaturing, annealing,
and extending. Amplification of the final PCR product was
confirmed by 2% agarose gel electrophoresis, and the products
werepurified using QIAquick PCR purificationkits (QIAGEN).
TheresultingDNAfragmentandthepET28vectorweredigested
in1  NEBuffer2 (NewEngland Biolabs) withNdeIa ndHindIII
at 37 C for 15 h. The digested products were purified by agarose
gel electrophoresis followed by use of a QIAquick gel extraction
FIGURE 1: Biosynthesis of lantibiotics/lantipeptides by four classes
of synthetases. (A) Posttranslational modification of precursor pep-
tides by lantibiotic/lantipeptide synthetases. Following ribosomal
synthesis of the precursor peptides (LanA), LanB, LanM, RamC/
LabKC, or LanL enzymes catalyze dehydration ofSer/Thr toafford
Dha/Dhb. For class II, III, and IV lantipeptides, this modification
proceeds through a two-step process, phosphorylation of Ser/Thr
and subsequent β-elimination of the phosphate to generate Dha/
Dhb. LanC, LanM, or LanL enzymes then catalyze intramolecular
addition of Cys thiols onto the dehydro amino acids in a stereo- and
regioselective manner to form Lan and MeLan. How the RamC/
LabKC proteins catalyze cyclization is currently not known. (B)
Illustration of the domain composition of class I-IV lanthionine
synthetases. The positions of active site residues (in LanC) or
conserved residuesin LanM, RamC/LabKC, and LanL correspond-
ing to the active site residues in structurally characterized homo-
logous enzymes are shown in darker colors. (C) Primary sequence of
VenA.Thedehydrationsitesarehighlightedinred.Theputativecore
peptide is underlined. (D) Domain composition of VenL-ΔC, a
truncated analogue of VenL lacking its LanC-like cyclase domain.Article Biochemistry, Vol. 50, No. 5, 2011 893
kit (QIAGEN). The resulting DNA insert was ligated with the
digested pET28vector at 24C for 3 h using T4 DNAligase. The
ligation reactionmixturewasdiluted 10timeswithwater priorto
transformation. E. coli DH5R cells were transformed with the
ligation product via heat shock, plated on LB-kanamycin agar
plates, and grown at 37 C for 15 h. Three colonies were picked
and incubated in 5 mL of LB-kanamycin medium at 37 Cf o r
15 h, followed by isolation of the plasmids using a QIAprep Spin
Miniprep Kit (QIAGEN). The sequences of the resulting plas-
mids were confirmed by DNA sequencing.
Construction of lctM Mutant Genes. The amplification of
lctM/pET28wasconductedvia30cyclesofdenaturing(98Cfo r
10 s), annealing (55 C for 30 s), and extending (72 C for 135 s)
using appropriate mutant primers (see Table S1 of the Support-
ing Information for oligonucleotide sequences). The PCRs
(50 μL) included 1  HF buffer (Finnzymes), DMSO (4%),
Phusion Hot Start High-Fidelity DNA Polymerase (Finnzymes)
(0.04unit/μL), dNTPs (2 mM), lctM/pET28(20ng),andprimers
(1 μM each). The PCR product was checked ona 1%agarose gel
andpurified usinga QIAquickPCR purification kit (QIAGEN).
The resulting DNA was treated with DpnIa t3 7C for 15 h to
digest the methylated template, and E. coli DH5R cells were
transformed. The desired mutations were confirmed by DNA
sequencing.
Overexpression and Purification of VenL-ΔC Mutants
and LctM Mutants. BL21(DE3) cells transformed with a
pET28 vector carrying each mutant gene were grown in 2 L of
LB medium containing 50 mg/L kanamycin at 37 C until the
OD600 reached ∼0.6. The incubation temperature was then
changed to 18 C, and the culture was induced with 0.2 mM
IPTG. The induced cells were shaken continually at 18 C for an
additional 18 h. The cells were harvested by centrifugation
(11900g for 10 min, Beckman JLA-10.500 rotor). The cell pellet
was resuspended in 30 mL of start buffer [50 mM HEPES3Na
(pH7.4),300mMNaCl,and10%glycerol,containingaprotease
inhibitor cocktail from Roche Applied Science] and stored
at -80 C.
Allpurificationstepswereperformedat4C.Cellpasteinstart
buffer was sonicated on ice for 20 min. After centrifugation
(23700g for 30 min, Beckman JA-20 rotor), the supernatant was
filtered through a 0.45 μm syringe filter. The sample was then
loaded onto a 5 mL HisTrap HP column (GE Healthcare Life
Sciences). The column was washed with 20 mL each of start
buffer containing 25 and 50 mM imidazole and then 10 mL each
of start buffer containing 100, 200, and 500 mM imidazole. The
eluent was collected in several fractions, which were analyzed by
Tris-SDS-PAGE. The fractions containing the desired protein
(200-500mMimidazole)werecombinedandconcentratedusing
an Amicon Ultra-15 centrifugal filter unit (30 kDa molecular
mass cutoff for His6-VenL, 10 kDa molecular mass cutoff for
other proteins, Millipore) to less than 2 mL. Buffer exchange of
the concentrated protein with start buffer was conducted twice
using a PD-10 desalting column (GE Healthcare Life Sciences).
Theresultingproteinsamplewasaliquotedandstoredat-80 C.
Protein concentrations were determined using a BCA protein
assay kit (Pierce Biotechnology).
InVitroLyaseActivityAssayofVenL-ΔCMutants.The
VenA substrate peptide was incubated with a VenL-ΔCm u t a n t
(final concentration of 2 μM) in a reaction buffer that contained
(final concentrations) 50 mM HEPES3Na buffer (pH 7.5),
FIGURE 2: Sequencealignmentanalysisofthelyase-likedomainsofLanLandRamCproteinsandOspFenzymes.Identical,similar,andpartially
conserved residues among theLanL,RamC, and OspFfamilymembersarehighlightedinred,pink, andgray, respectively. Theresiduesthatare




residues responsible for the recognition of pTyr present in the substrate MAPK in SpvC. VenL (GenBank accession number HQ328852), SclL
(YP_002193147), SoeL1 (YP_001106221), SgrL (AAP03109), SoeL2 (YP_001106807), SgiL (YP_001821664), RamC (NP_630756), LabKC
(CAX48971), AmfT (YP_001823909), OspF (YP_406014), SpvC (YP_002635578), VirA (NP_790745), and HopAI1 (NP_790745).894 Biochemistry, Vol. 50, No. 5, 2011 Goto et al.
10 mM MgCl2, 2.5 mM ATP, 1 mM TCEP, 25 μM VenA, and
5% DMSO. The reaction mixture was incubated at 25 Cf o r2h
(standard) or 20 h (see Figures S1 and S2 of the Supporting
Information). For mass spectrometric analysis, 10 μLo ft h e
reactionmixturewasdesaltedusingZipTipC18(Millipore),eluted
with 1 μL of a 75% MeCN/25% water solution containing 0.1%
TFA and saturated with sinapinic acid, and spotted onto the
target plate for analysis using a Voyager-DE-STR mass spectro-
meter (Applied Biosystems).
In Vitro Lyase Activity Assay of LctM Mutants. The
LctA substrate peptide was incubated with a LctM mutant (final
concentration of 2 μM) in a reaction buffer that contained (final
concentrations)50mMTris3HClbuffer(pH7.5),10mMMgCl2,
1 mM ATP, 1 mM TCEP, 25 μg/mL BSA, 25 μM LctA, and 5%
DMSO.Thereactionmixturewasincubatedat25Cfo r2h .Fo r
mass spectrometric analysis, 10 μLo ft h er e a c t i o nm i x t u r ew a s
desalted using ZipTipC18 (Millipore), eluted with 1 μL of a 75%
MeCN/25% water solution containing 0.1% TFA and satu-
rated with sinapinic acid, and spotted onto the target plate for
analysis using a Voyager-DE-STR mass spectrometer (Applied
Biosystems).
RESULTS
pSer/pThr Lyase Activity of VenL-ΔC Proteins Mu-
tated at Residues Strictly Conserved among Members of
the LanL and OspF Families. VenL is a member of the LanL
family, and its activity has been reconstituted in vitro (1). The
enzymecatalyzesfourdehydrationsfollowedbyfourcyclizations
of its substrate peptide VenA (Figure 1C). The deletion mutant
VenL-ΔC lacks its C-terminal cyclase domain; it retains the
native dehydratase activity but has no cyclase activity
(Figure 1D). We used this deletion mutant to further investigate
the dehydrationreaction. The residues that are conservedamong
the OspF, LanL, and RamC families and that are located in the
activesiteinOspFfamilymemberSpvC(K104,H106,K136,and
Y158) were first targeted for mutation. Thus, the genes encoding
His6-VenL-ΔC variants with K51M, H53N, H53F, K80M, and
Y108F mutations were generated via overlap extension PCR.
The proteins were overexpressed in E. coli and purified by
immobilized metal affinity chromatography.
To evaluate the lyase activity of each VenL-ΔC mutant, we
incubatedtheVenApeptidewitheachmutantandthensubjected
each to MALDI-ToF MS. Incubation of VenA with wild-type
VenL-ΔCa t2 5C for 2 h in the presence of ATP, MgCl2,a n d
TCEP resulted in 4-fold dehydrated VenA (Figure 3A,B). In
contrast, VenL-ΔLC, a VenL variant lacking both lyase and
cyclase domains, catalyzed conversion of VenA into a mixture of
peptides carrying multiple (up to four) phosphate groups
(Figure 3C). Under these reaction conditions, His6-VenL-ΔC-
K80M yielded only the 4-fold phosphorylated intermediate,
indicating that this mutant lost pSer/pThr lyase activity
(Figure 3D). In the mass spectrum of VenA after treatment with
VenL-ΔC-K51M, peaks corresponding to the fully phosphory-
lated substrate as well as 3-fold phosphorylated peptide that also
had undergone elimination of a phosphate group were detected
(Figure 3E). After incubation for 20 h, the 2-fold dehydrated
peptide was detected but no further dehydrated VenA peptides
were observed (Figure S1B of the Supporting Information). This
result shows that VenL-ΔC-K51M does not catalyze efficient β-
elimination.Similarly,replacementofHis53withanAsnresulted
inamutantVenL-ΔCthatwasabletopartiallybutnotcompletely
dehydrate the substrate, and VenL-ΔC-H53F was incapable of
eliminating phosphate from pSer/pThr on VenA (Figure 3F,G).
In contrast, mutation of Tyr108, which corresponds to Tyr158 in
SpvC that forms a hydrogen bond with the carbonyl oxygen of
FIGURE 3: MALDI-ToF MS analysis of VenA processed by VenL-
ΔC derivatives having a mutation at the predicted catalytic site
residues. Mass spectra of (A) VenA and of VenA after incubation
with (B) wild-type VenL-ΔC, (C) VenL-ΔLC, (D) VenL-ΔC-K80M,
(E) VenL-ΔC-K51M, (F) VenL-ΔC-H53N, (G) VenL-ΔC-H53F,
and (H) VenL-ΔC-Y108F. The assignments for the observed peaks
are shown in the spectra, in which SM indicates the starting material
(VenA).Article Biochemistry, Vol. 50, No. 5, 2011 895
pThr in the substrate and assists deprotonation of the R-
proton (16), was not critical in the lyase reaction catalyzed by
VenL as the completely dehydrated peptide was detected in the
mass spectrum of VenA incubated with VenL-ΔC-Y108F
(Figure3H).MutationofThr106toAlaalsoresultedinaprotein
that was able to complete the 4-fold dehydration of VenA in 2 h
(Figure S2A of the Supporting Information). A double mutant,
VenL-ΔC-T106A/Y108F, also dehydrated the substrate (Figure
S2B,C of the Supporting Information).
pSer/Thr Lyase Activity of VenL-ΔC Proteins Mutated
atResiduesConservedOnlyintheLanLFamily. Inaddition
to investigation of the residues that are conserved in both the
LanL and OspF families, the importance of residues that are
conserved only in the LanL and RamC families was assessed.
Mutagenesis of Trp50 (W50D and W50A) resulted in enzymes
that still phosphorylated VenA but did not display detectable
dehydration activity (Figure 4A and Figures S1E and S2D,E of
the Supporting Information). Furthermore, the His6-VenL-ΔC-
K103A mutant predominantly phosphorylated the substrate
peptide, with some dehydrated peptides observed after incuba-
tion for 20 h (Figure 4B and Figure S1F of the Supporting
Information), demonstrating that Lys103 is important but not
essential for the lyase activity of VenL. In the case of VenL-ΔC-
D137N, although 4-fold dehydrated VenA was not the major
product, varying amountsofpeptides withthree or two dehydra-
tions were observed after incubation for 2 and 20 h (Figure 4C
and Figure S1G of the Supporting Information), suggesting
decreasedbutnotcompletelyabolishedlyaseactivityofthemutant.
However, His6-VenL-ΔC-R149M yielded 4-fold phosphorylated
VenA as the major product along with small amounts of mono-
anddidehydratedpeptides,demonstratingtheweaklyaseactivity
of this mutant (Figure 4D and Figure S1H of the Supporting
Information). Conversely, mutation of Arg156 to Met did
not have a deleterious effect as the mutant enzyme catalyzed
the 4-fold dehydration of VenA (Figure S2F of the Supporting
Information).
Sequence Homology among All Four Lantibiotic/Lanti-
peptide Synthetase Families and Mutagenesis of the Con-
served Residues. Although the lyase domain of members of the
LanL and RamC families does not display obvious sequence
similarity with that of members of the two other lantipeptide
dehydratase families (LanB and LanM), close examination of
multiple-sequence alignments exhibits two weakly homologous
regions (Figure 5A,B). The first is a “G-(K/R)-(F/A)” motif that
includes Lys103 of VenL that was shown in the studies discussed
above to be important for elimination. The second motif was
found in only LanL, RamC, and LanM; it is located around the
invariantArg149ofVenLandcontainsaconserved basic residue
flanked by multiple aromatic or hydrophobic residues. Because
bothhomologous areas includea conserved residue that playsan
importantroleinthelyaseactivityofVenL,wehypothesizedthat
the detected conserved residues might also be important for the
dehydration reaction by LanM and LanB. To address this
hypothesis, the putative conserved residues were mutated in
LctM, a representative LanM enzyme whose in vitro activity
hasbeen studied (7,12-14,19-21).Unfortunately,wecouldnot
test the activity of mutants of LanB family members, as in vitro
reconstitutionof dehydratase activity of the LanB family has not
been achieved thus far (22-24).
To evaluate the reliability of the first homologous region, we
constructed His6-LctM-K144A. When LctA, the canonical sub-
stratepeptideofLctM,wasincubatedwithHis6-LctM-K144Ain
the presence of ATP and Mg
2þ, completely (4-fold) dehydrated
peptide was generated, suggesting that Lys144 of LctM is not
essential for lyase activity (Figure 5C). Three additional LctM
mutants, LctM-Y225A, LctM-K227M, and LctM-R226M/
K227M, were prepared to evaluate the importance of the second
homologous region. All mutants were able to dehydrate LctA
four times (Figure 5D-F). Taken together, the mutagenesis
analysisofLctMsuggeststhattheobservedsequencehomologies
among the lantibiotic/lantipeptide synthetase families shown in
Figure 5 do not have functional significance.
DISCUSSION
The mutagenesis studies of VenL-ΔC performed in this work
provide further experimental support for the idea that LanL
enzymes utilize their pSer/pThr lyase domain to complete dehy-
drationofSer/Thrresiduesintheirsubstrates.Someoftheamino
acids that have been reported to be important for this activity in
members of the OspF family are shown here to be important for
VenL also. In the proposed catalytic mechanism of SpvC based
on its X-ray structure (16, 17) (Figure 6A), the carbonyl oxygen
of pThr of the substrate makes two hydrogen bonding contacts
with the ε-amine of Lys104 and the hydroxyl group of Tyr158,
resulting in a decrease in the pKa of the R-proton of the pThr.
Lys136 is believed to be the catalytic base that abstracts this R-
proton to form an enolate and trigger the β-elimination reaction,
with His106 protonating the bridging oxygen of the phosphate
ester (16). Inaddition, several other residues could beinvolved in
the recognition of the phosphate group of pThr as several
FIGURE 4: MALDI-ToF MS analysis of VenA processed by VenL-
ΔC derivatives having a mutation of the residues conserved only in
the LanL and RamC families but not in the OspF family. Mass
spectra of VenA after incubation with (A) VenL-ΔC-W50D, (B)
VenL-ΔC-K103A, (C) VenL-ΔC-D137N, and (D) VenL-ΔC-
R149M. The assignments for the observed peaks are shown in the
spectra, in which SM indicates the starting material (VenA).896 Biochemistry, Vol. 50, No. 5, 2011 Goto et al.
possible hydrogen bonds with Arg148, Arg213, and Arg220 were
suggested by the crystal structure (16, 17).
The proposed catalytic base residue in the OspF family
(Lys136) is well-conserved in LanL enzymes, and mutation of
the corresponding Lys80 in VenL-ΔC shows it is essential for
catalysis of the β-elimination reaction. The observation that the
VenL-ΔC-H53NandVenL-ΔC-H53Fmutantsalsolostthelyase
activity is consistent with the hypothesis that this invariant His
(corresponding to His106 in SpvC) acts as a catalytic acid
protonating the bridging oxygen of the phosphate leaving group.
Lys51 of VenL, corresponding to Lys104 in SpvC, also plays an
important role in VenL on the basis of the mutagenesis results,
suggestingthatthisresidueactivatesthecarbonyloxygenofpSer/
pThr and assists deprotonation of its R-proton.
Ontheotherhand,mutagenesisofTyr108,whichiscompletely
conserved among members of the LanL, RamC, and OspF
families, did not affect the lyase activity of VenL-ΔC. This
observation is in sharp contrast to replacement of Tyr158 in
FIGURE 6: Proposedmechanism ofthelyasereactioncatalyzedbyVenL.(A)ModeledstructureoftheactivesiteofSpvC.Thestructureisbased
on the crystal structure of the SpvC-K136A mutant-substrate complex (Protein Data Bank entry 2Q8Y) and was generated by replacement of
Ala136withalysine.(B) ModeledstructureofthelyasedomainofVenL.ThemodelwasgeneratedbytheSWISS-MODELhomologymodeling
server on the basis of the crystal structure of a SpvC mutant complexed with its substrate peptide (Protein Data Bank entry 2Q8Y) and the
alignment shown inFigure2.Substrate peptidescontaining a pThrresidue are shown asyellowribbons withthe pThrshown assticks. Predicted
hydrogen bonds are represented by green dashed lines. Interactions between the proposed catalytic base residue and the R-proton of pThr in the
substrate are denoted with magenta arrows. (C) Proposed mechanism for β-elimination of the phosphate of pSer/Thr catalyzed by the lyase
domain of VenL. The substrate peptide and active site residues are colored orange and navy, respectively.
FIGURE 5: Site-directedmutagenesisofLctM.(A)PartialsequencealignmentofLanL,LanB,andLanMproteins.Theresiduenumberingatthe
top is from VenL, whereas the residue numbering at the bottom is from LctM. (B) Partial sequence alignment of LanL and LanM proteins.
Identical, similar, and partially conserved residues are highlighted in red, pink, and gray, respectively. The conserved residues within only one
proteinfamilyarehighlightedincyan(LanL)andgreen(LanM).RedstarsindicatetheresiduesthatareimportantforthelyaseactivityofVenL.
The residues in LctM marked withblack squares were mutated in this study. Residue numbering for VenL and LctM is shown in cyan(top) and
green(bottom),respectively.NisB(GenBankaccessionnumberCAA48381),MutB(AAG48566),EpiB(CAA44253),PepB(CAA90025),GeoM
(YP_001126159),MrsM(CAB60261),NukM(NP_940773),andLctM(AAC72258).(C-F)MALDI-ToFMSanalysisofLctAprocessedby(C)
LctM-K144A, (D) LctM-Y225A, (E) LctM-K227M, and (F) LctM-R226M/K227M. The assignments for observed peaks are shown in the
spectra, in which SM indicates the starting material (LctA).Article Biochemistry, Vol. 50, No. 5, 2011 897
SpvC with a Phe, which resulted in a drastic decrease in
catalytic activity (16). Thr106, located near Tyr108 and also
conserved among members of the three families, was also not
critical for the β-elimination reaction by the lyase domain of
VenL. Thus, it is not clear which residue in LanL may play a
rolesimilartothatofTyr158ofSpvC.Perhapsactivationofthe
carbonyl group of pSer/pThr by Lys104 in the lyase domain of
LanL is sufficient.
The sequence alignment and mutagenesis results also demon-
strate some differences between the LanL/RamC and OspF
families. For instance, a (V/I)-D-K sequence conserved in OspF
(Val132-Lys134inSpvC)nearthecatalyticbaseisnotpresentin
the LanL and RamC proteins. Lys134 in SpvC recognizes a
phosphate of a phosphotyrosine (pTyr) present in its substrate
MAPK in a pTyr-X-pThr motif. Presumably because such a
pTyr residue is not present in the LanA substrate peptides,
Lys134 is not conserved in the LanL and RamC families.
Mutation of residues that are conserved in members of the
LanLandRamCfamiliesbutnotinmembersoftheOspF family
showed that several are important for lyase activity. VenL-ΔC-
W50D did not catalyze β-elimination of pSer/pThr in the VenA
peptide; members of the OspF family have a conserved Asp
residue at the corresponding position that has not been investi-
gated by mutagenesis. Likewise, when Lys103 was replaced with
Ala (the residue that is conserved at this position in OspF), the
resulting VenL-ΔC mutant was devoid of measurable lyase
activity. The function of these two residues is not immediately
clear from the SpvC structure. Asp103 and Ala153 in SpvC, the
residues corresponding to Trp50 and Lys103 in VenL, respec-
tively, are located near the active site, but they do not make
contacts with the substrate peptide in the crystal structure
(Figure 6A). VenL-ΔC-D137N also exhibited a significant de-
creaseinlyaseactivity;GlnandAsnarefoundatthecorrespond-
ing positions in SpvC and HopAI1, respectively. Determination
oftheexactroleoftheseresidues(Trp50,Lys103,andAsp137) in
the VenL-catalyzed lyase reaction would be aided by structural
information.
To date, we have been unable to obtain a crystal structure of
VenL or its individual domains. To still provide insights into the
potential role of these residues, we built a structural model of the
VenL lyase domain with the SWISS-MODEL server using the
crystal structure of SpvC (Protein Data Bank entry 2Q8Y) and
the sequence alignment between SpvC and VenL shown in
Figure 2 (Figure 6B). The active site model provides further
support for the idea that Lys51, His53, and Lys80 in VenL likely
play roles similar to those of Lys104, His106, and Lys136 in
SpvC. On the other hand, it appears that recognition of the
phosphate leaving group is achieved quite differently. In the
crystal structure of SpvC, in addition to His53, three arginines
(Arg148,-213,and -220) interactwiththephosphate,butnoneof
theseargininesisconservedinVenL.Instead,a differentarginine
and a lysine (Arg156 and Lys103 corresponding to Glu215 and
Ala153 in SpvC, respectively), which are not conserved in
members of the OspF family, are located near the phosphate
on the substrate peptide. The observation that mutation at
Lys103 resulted in a loss of the catalytic activity is consistent
with an important role of this residue. In contrast, Arg156 does
notappeartobeimportantbecausemutationinVenL-ΔCtoMet
did not inactivate its lyase activity. The homology model did not
provide insights into why the Trp50, Asp137, and Arg149
mutants are impaired with respect to lyase activity. On the basis
of the collective results obtained in this study, we propose the
mechanism shown in Figure 6C for the anti elimination reaction
catalyzed by LanL.
Although weak sequence homologies among members of the
LanL, LanB, and LanC families in the regions containing the
residues important for the lyase activity in VenL [Lys103 and
Arg149 (Figure 5A,B)] suggested the possibility that all three
enzyme families share a common strategy for catalyzing dehy-
dration of Ser/Thr, mutagenesis analysis of the corresponding
residues in LctM showed that they do not play essential roles in
dehydration. Thus, the question of whether the elimination
reaction in LanM proteins takes place in the same active site as
phosphorylation or whether this class of enzymes also has a
separate lyase domain remains unresolved.
In summary, the mutagenesis study of VenL-ΔCi nt h i sp a p e r
provides the first mechanistic insights into the dehydration
reaction catalyzed by members of the LanL enzyme family.
The data described here indicate that LanL enzymes and the
OspFfamilyshareasimilarcatalyticstrategyforβ-eliminationof
phosphate groups of pSer/pThr to afford dehydro amino acids,
but that their substrate recognition mechanism differs. These
findings support our previous hypothesis that LanL and OspF
proteinshaveevolvedfromacommonprimitivepSer/pThrlyase.
The OspF proteins evolved high substrate specificity in part by
the recognition of the pTyr present in their substrates. On the
other hand, the LanL family may have evolved via gene fusion
eventsamongstand-aloneSer/Thrkinases,pSer/pThrlyases,and
LanC-like cyclases, which retained their primordial substrate
promiscuity that allows these enzymes to process multiple Ser/
Thr residues in a substrate peptide.
SUPPORTING INFORMATION AVAILABLE
Mass spectrometric data of assays with mutant enzymes
and sequences of oligonucleotide primers used in this study.
This material is available free of charge via the Internet at http://
pubs.acs.org.
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